Cargando…
Biological and pharmacological roles of m(6)A modifications in cancer drug resistance
Cancer drug resistance represents the main obstacle in cancer treatment. Drug-resistant cancers exhibit complex molecular mechanisms to hit back therapy under pharmacological pressure. As a reversible epigenetic modification, N(6)-methyladenosine (m(6)A) RNA modification was regarded to be the most...
Autores principales: | Liu, Zaoqu, Zou, Haijiao, Dang, Qin, Xu, Hui, Liu, Long, Zhang, Yuyuan, Lv, Jinxiang, Li, Huanyun, Zhou, Zhaokai, Han, Xinwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749187/ https://www.ncbi.nlm.nih.gov/pubmed/36517820 http://dx.doi.org/10.1186/s12943-022-01680-z |
Ejemplares similares
-
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
por: Liu, Zaoqu, et al.
Publicado: (2022) -
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022) -
Exploring the roles of intestinal flora in enhanced recovery after surgery
por: Liu, Zaoqu, et al.
Publicado: (2023) -
Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance
por: Ren, Yuqing, et al.
Publicado: (2023) -
Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis
por: Ren, Yuqing, et al.
Publicado: (2023)